HealthEquity Appoints New CFO, Elects Directors
Ticker: HQY · Form: 8-K · Filed: Jun 27, 2024 · CIK: 1428336
| Field | Detail |
|---|---|
| Company | Healthequity, INC. (HQY) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, cfo-appointment
Related Tickers: HQY
TL;DR
HealthEquity names new CFO, Steven Steele, effective July 1st, and adds him to the board.
AI Summary
HealthEquity, Inc. announced on June 27, 2024, a series of significant corporate actions. These include the appointment of Steven A. Steele as Chief Financial Officer, effective July 1, 2024, and the election of new directors, including Mr. Steele, to the Board. The company also disclosed executive compensation arrangements and matters submitted for a security holder vote.
Why It Matters
The appointment of a new CFO and changes to the board of directors can signal strategic shifts or governance updates within the company, potentially impacting investor confidence and future financial performance.
Risk Assessment
Risk Level: medium — Changes in key executive positions like CFO and board composition can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- HealthEquity, Inc. (company) — Registrant
- Steven A. Steele (person) — Appointed Chief Financial Officer and Director
- June 27, 2024 (date) — Date of Report
- July 1, 2024 (date) — Effective date for CFO appointment
FAQ
Who has been appointed as the new Chief Financial Officer of HealthEquity, Inc.?
Steven A. Steele has been appointed as the new Chief Financial Officer of HealthEquity, Inc., effective July 1, 2024.
When is Steven A. Steele's appointment as CFO effective?
Steven A. Steele's appointment as CFO is effective July 1, 2024.
Has Steven A. Steele also been appointed to the Board of Directors?
Yes, Steven A. Steele has been elected to the Board of Directors of HealthEquity, Inc.
What other items are reported in this 8-K filing?
This 8-K filing also reports on the election of directors, compensatory arrangements of certain officers, and the submission of matters to a vote of security holders.
What is the principal executive office address for HealthEquity, Inc.?
The principal executive office address for HealthEquity, Inc. is 15 West Scenic Pointe Drive, Suite 100, Draper, Utah 84020.
Filing Stats: 1,036 words · 4 min read · ~3 pages · Grade level 11 · Accepted 2024-06-27 16:03:38
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share HQY The NASDAQ Global Select
Filing Documents
- hqy-20240627.htm (8-K) — 51KB
- 0001428336-24-000048.txt ( ) — 178KB
- hqy-20240627.xsd (EX-101.SCH) — 2KB
- hqy-20240627_lab.xml (EX-101.LAB) — 22KB
- hqy-20240627_pre.xml (EX-101.PRE) — 13KB
- hqy-20240627_htm.xml (XML) — 3KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 27, 2024, the Company held its 2024 Annual Meeting. As of the close of business on May 3, 2024, the record date for the Annual Meeting, 87,009,915 shares of common stock of the Company were issued and outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, the stockholders voted on four proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on May 17, 2024. Stockholders approved each of the proposals presented for a vote. The tables below set forth the number of votes cast for and against, and the number of abstentions or broker non-votes, for each matter voted upon by the Company's stockholders. Proposal 1. The election of ten directors to hold office until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified. For Against Abstain Broker Non-Votes Robert Selander 76,943,718 1,540,430 75,377 3,774,705 Jon Kessler 78,241,749 266,516 51,260 3,774,705 Stephen Neeleman, M.D. 77,945,113 563,212 51,200 3,774,705 Paul Black 78,192,846 312,010 54,669 3,774,705 Adrian Dillon 78,224,099 280,669 54,757 3,774,705 Evelyn Dilsaver 77,717,584 787,566 54,375 3,774,705 Debra McCowan 77,744,695 744,453 70,377 3,774,705 Rajesh Natarajan 78,296,897 207,611 55,017 3,774,705 Stuart Parker 78,235,908 252,677 70,940 3,774,705 Gayle Wellborn 77,964,390 540,134 55,001 3,774,705 Proposal 2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2025. There were no broker non-votes for this proposal. For Against Abstain 81,967,216 303,024 63,990 Proposal 3. The approval, on a non-binding, advisory basis, of the fiscal 2024 compensation paid to the Company's named executive officers. For Against Abstain Broker Non-
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1 HealthEquity, Inc. 2024 Equity Incentive Plan 104 Cover Page Interactive Data File (formatted in Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHEQUITY, INC. Date: June 27, 2024 By: /s/ James Lucania Name: James Lucania Title: Executive Vice President and Chief Financial Officer